BioHarvest Sciences Inc. Delivers a 380% Increase in Monthly E-Commerce Revenue with Its 2020 Launch of Vinia B2C Online Business in Israel Biotech Investing
Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV Biotech Investing
Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company's Leading Cardiovascular Franchise Biotech Investing
The Bristol Myers Squibb Foundation and National Medical Fellowships Launch $100 Million Program to Help Increase Diversity and Inclusion in Clinical Trials Biotech Investing
Algernon Pharmaceuticals Announces Receipt of Refundable Tax Credit from Australian Clinical Research Biotech Investing
